Literature DB >> 11849439

Inhibition of inducible nitric oxide synthase reduces renal ischemia/reperfusion injury.

Prabal K Chatterjee1, Nimesh S A Patel, Espen O Kvale, Salvatore Cuzzocrea, Paul A J Brown, Keith N Stewart, Helder Mota-Filipe, Christoph Thiemermann.   

Abstract

BACKGROUND: Nitric oxide (NO), produced via inducible nitric oxide synthase (iNOS), is implicated in the pathophysiology of renal ischemia/reperfusion (I/R) injury. The aim of this study was to investigate the effects of the iNOS inhibitors L-N6-(1-iminoethyl)lysine (L-NIL) and aminoethyl-isothiourea (AE-ITU) on (a) renal dysfunction and injury mediated by bilateral I/R of rat kidneys in vivo and (b) cytokine-stimulated NO production by primary cultures of rat proximal tubule (PT) cells.
METHODS: Male Wistar rats subjected to bilateral renal ischemia (45 min) followed by reperfusion (6 h). Rats were administered either L-NIL (3 mg/kg IV bolus 15 min prior to I/R followed by 1 mg/kg/h throughout I/R) or AE-ITU (1 mg/kg IV bolus 15 min prior to I/R followed by 1 mg/kg/h throughout I/R). Serum and urinary biochemical indicators of renal dysfunction and injury were measured; serum creatinine (SCr, glomerular dysfunction), fractional excretion of Na+ (FENa, tubular dysfunction), serum aspartate aminotransferase (sAST, I/R injury) and urinary N-acetyl-beta-d-glucosaminidase (uNAG, tubular injury). Additionally, renal sections were used for histological grading of renal injury and for immunological evidence of nitrotyrosine formation. Nitrate/nitrate levels in plasma were measured using the Griess assay and used as an indicator of NO production. Primary cultures of rat PT cells were incubated with interferon-gamma(IFN-gamma, 100 IU/mL) and lipopolysaccharide (LPS, 10 microg/mL) for 24 h, either in the absence or presence of increasing concentrations of L-NIL or AE-ITU (0.001 to 1 mmol/L) after which nitrite/nitrate levels were measured using the Griess assay.
RESULTS: L-NIL and AE-ITU significantly reduced the I/R-mediated increases in SCr, FENa, sAST and uNAG, indicating attenuation of I/R-mediated renal dysfunction and injury. Specifically, L-NIL and AE-ITU reduced the I/R-mediated glomerular and tubular dysfunction and biochemical and histological evidence of tubular injury. Both L-NIL and AE-ITU attenuated the plasma levels of nitrate (indicating reduced NO production) and the immunohistochemical evidence of the formation of nitrotyrosine. In vitro, L-NIL and AE-ITU both significantly reduced cytokine-stimulated NO production by primary cultures of rat PT cells in a dose-dependent manner.
CONCLUSIONS: These results suggest that L-NIL and AE-ITU reduce the renal dysfunction and injury associated with I/R of the kidney, via inhibition of iNOS activity and subsequent reduction of NO (and peroxynitrite) generation. We propose that selective and specific inhibitors of iNOS activity may be useful against the NO-mediated renal dysfunction and injury associated with I/R of the kidney.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11849439     DOI: 10.1046/j.1523-1755.2002.00234.x

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  49 in total

1.  Naloxone pretreatment prevents kidney injury after liver ischemia reperfusion injury.

Authors:  Mohammad Ashrafzadeh Takhtfooladi; Mehran Shahzamani; Ahmad Asghari; Aris Fakouri
Journal:  Int Urol Nephrol       Date:  2016-04-07       Impact factor: 2.370

2.  Inducible nitric oxide synthase inhibition reverses pulmonary arterial dysfunction in lung transplantation.

Authors:  Jing-Xiang Wu; Hong-Wei Zhu; Xu Chen; Jiong-Lin Wei; Xiao-Feng Zhang; Mei-Ying Xu
Journal:  Inflamm Res       Date:  2014-04-24       Impact factor: 4.575

3.  Nobiletin Protects from Renal Ischemia-Reperfusion Injury in Rats by Suppressing Inflammatory Cytokines and Regulating iNOS-eNOS Expressions.

Authors:  Mehmet Güvenç; Mustafa Cellat; Ahmet Uyar; Hüseyin Özkan; İshak Gokcek; Cafer Tayer İsler; Akın Yakan
Journal:  Inflammation       Date:  2020-02       Impact factor: 4.092

4.  Growth arrest-specific protein 6 protects against renal ischemia-reperfusion injury.

Authors:  Matthew D Giangola; Weng-Lang Yang; Salil R Rajayer; Michael Kuncewitch; Ernesto Molmenti; Jeffrey Nicastro; Gene F Coppa; Ping Wang
Journal:  J Surg Res       Date:  2015-05-29       Impact factor: 2.192

5.  Tubular stress proteins and nitric oxide synthase expression in rat kidney exposed to mercuric chloride and melatonin.

Authors:  Alessandra Stacchiotti; Francesca Ricci; Rita Rezzani; Giovanni Li Volti; Elisa Borsani; Antonio Lavazza; Rossella Bianchi; Luigi Fabrizio Rodella
Journal:  J Histochem Cytochem       Date:  2006-06-26       Impact factor: 2.479

6.  The effects of PDE5 inhibitory drugs on renal ischemia/reperfusion injury in rats.

Authors:  A Küçük; M Yucel; N Erkasap; M Tosun; T Koken; M Ozkurt; S Erkasap
Journal:  Mol Biol Rep       Date:  2012-06-27       Impact factor: 2.316

7.  Comparative study on the protective role of vitamin C and L-arginine in experimental renal ischemia reperfusion in adult rats.

Authors:  Abd El-Hamid A Mohamed; Noha N Lasheen
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2014-10-11

8.  Thyroxine prevents reoxygenation injury in isolated proximal tubule cells.

Authors:  Elif Erkan; Abdullah Sakarcan; Gonca Haklar; Suha Yalcin
Journal:  Pediatr Nephrol       Date:  2003-05-07       Impact factor: 3.714

9.  IL-18 contributes to renal damage after ischemia-reperfusion.

Authors:  Huiling Wu; Melissa L Craft; Peng Wang; Kate R Wyburn; Gang Chen; Jin Ma; Brett Hambly; Steven J Chadban
Journal:  J Am Soc Nephrol       Date:  2008-09-24       Impact factor: 10.121

10.  Favorable balance of anti-oxidant/pro-oxidant systems and ablated oxidative stress in Brown Norway rats in renal ischemia-reperfusion injury.

Authors:  Vani Nilakantan; Gail Hilton; Cheryl Maenpaa; Scott K Van Why; Galen M Pieper; Christopher P Johnson; Brian D Shames
Journal:  Mol Cell Biochem       Date:  2007-04-26       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.